Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1981 1
1984 2
1988 1
1989 2
1990 1
1991 2
1992 2
1997 1
1998 1
2000 2
2002 2
2007 1
2008 2
2009 2
2010 3
2012 2
2013 2
2015 1
2016 1
2017 2
2018 3
2019 6
2020 3
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, Mulenga H, Hanekom WA, Self SG, Bekker LG, Ryall R, Gurunathan S, DiazGranados CA, Andersen P, Kromann I, Evans T, Ellis RD, Landry B, Hokey DA, Hopkins R, Ginsberg AM, Scriba TJ, Hatherill M; C-040-404 Study Team. Nemes E, et al. Among authors: ginsberg am. N Engl J Med. 2018 Jul 12;379(2):138-149. doi: 10.1056/NEJMoa1714021. N Engl J Med. 2018. PMID: 29996082 Free PMC article. Clinical Trial.
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, Van Brakel E, Salaun B, Scriba TJ, Akite EJ, Ayles HM, Bollaerts A, Demoitié MA, Diacon A, Evans TG, Gillard P, Hellström E, Innes JC, Lempicki M, Malahleha M, Martinson N, Mesia Vela D, Muyoyeta M, Nduba V, Pascal TG, Tameris M, Thienemann F, Wilkinson RJ, Roman F. Tait DR, et al. Among authors: ginsberg am. N Engl J Med. 2019 Dec 19;381(25):2429-2439. doi: 10.1056/NEJMoa1909953. Epub 2019 Oct 29. N Engl J Med. 2019. PMID: 31661198 Free article. Clinical Trial.
New hope for tuberculosis vaccines.
Olesen OF, Abdullah F, Coppens R, Gardner PJ, Ginsberg AM, Hanekom WA, Laang H, Lewinsohn DM, Loots G, Schmidt A, Vekemans J, Voss GH. Olesen OF, et al. Among authors: ginsberg am. Lancet Infect Dis. 2019 Jul;19(7):687-688. doi: 10.1016/S1473-3099(19)30280-4. Lancet Infect Dis. 2019. PMID: 31250810 No abstract available.
Drugs in development for tuberculosis.
Ginsberg AM. Ginsberg AM. Drugs. 2010 Dec 3;70(17):2201-14. doi: 10.2165/11538170-000000000-00000. Drugs. 2010. PMID: 21080738 Review.
TB vaccines in clinical development.
Ginsberg AM, Ruhwald M, Mearns H, McShane H. Ginsberg AM, et al. Tuberculosis (Edinb). 2016 Aug;99 Suppl 1:S16-20. doi: 10.1016/j.tube.2016.05.013. Epub 2016 Jun 16. Tuberculosis (Edinb). 2016. PMID: 27470538
Emerging drugs for active tuberculosis.
Ginsberg AM. Ginsberg AM. Semin Respir Crit Care Med. 2008 Oct;29(5):552-9. doi: 10.1055/s-0028-1085706. Epub 2008 Sep 22. Semin Respir Crit Care Med. 2008. PMID: 18810688 Review.
Innovative clinical trial designs to rationalize TB vaccine development.
Ellis RD, Hatherill M, Tait D, Snowden M, Churchyard G, Hanekom W, Evans T, Ginsberg AM. Ellis RD, et al. Among authors: ginsberg am. Tuberculosis (Edinb). 2015 May;95(3):352-7. doi: 10.1016/j.tube.2015.02.036. Epub 2015 Mar 6. Tuberculosis (Edinb). 2015. PMID: 25802031 Review.
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations.
Vekemans J, Brennan MJ, Hatherill M, Schrager L, Fritzell B, Rutkowski K, De Vos B, Zignol M, Thiry G, Ginsberg AM, Walker B. Vekemans J, et al. Among authors: ginsberg am. Vaccine. 2020 Jan 10;38(2):135-142. doi: 10.1016/j.vaccine.2019.10.072. Epub 2019 Nov 13. Vaccine. 2020. PMID: 31733944 Free article. Review.
47 results